Kin Yip Tam

13PUBLICATIONS
15CO-AUTHORS
Molecular targetsMedical devicesToxicology (incl. clinical toxicology)Predictive and prognostic markersBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 14, 2025
Targeting Metabolic Vulnerabilities Reveals Hexokinase 2 as a Key Mediator of Resistance to Osimertinib in Non-Small Cell Lung Cancer Models.

Yizhen Guo, Ding Huang, Yan Zhou

|Feb 05, 2025
Triple-Target Inhibition of Cholinesterase, Amyloid Aggregation, and GSK3β to Ameliorate Cognitive Deficits and Neuropathology in the Triple-Transgenic Mouse Model of Alzheimer's Disease.

Junqiu He, Shan Sun, Hongfeng Wang

|Aug 25, 2023
Epigallocatechin gallate circumvents drug-induced resistance in non-small-cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis.

Yan Zhou, Shiqi Huang, Yizhen Guo

|Jul 28, 2023
UBQLN2 and HSP70 participate in Parkin-mediated mitophagy by facilitating outer mitochondrial membrane rupture.

Qilian Ma, Jiaqi Xin, Qiang Peng

|Jul 06, 2023
Cytosolic malic enzyme and glucose-6-phosphate dehydrogenase modulate redox balance in NSCLC with acquired drug resistance.

Maoxin Ran, Yan Zhou, Yizhen Guo

|Oct 01, 2020
An Isoquinolinium Dual Inhibitor of Cholinesterases and Amyloid β Aggregation Mitigates Neuropathological Changes in a Triple-Transgenic Mouse Model of Alzheimer's Disease.

Yaojun Ju, Harapriya Chakravarty, Kin Yip Tam

Pageof 3

Frequent Collaborators

2 joint publications

Zheng Ying

2 joint publications

Hongfeng Wang

1 joint publications

Josef Jampilek

1 joint publications

Mark Olsen